Skip to content

Latest News

Aurobindo Pharma trades in red despite FDA nod to Eugia Pharma injection

Aurobindo Pharma trades in red despite FDA nod to Eugia Pharma injection

Aurobindo Pharma#39;s wholly owned subsidiary company, Eugia Pharma Specialities Limited received a final approval from the US Food Drug Administration (USFDA) to manufacture and market Azacitidine for Injection, 100 mg single-dose vial.

Read More

​ Aurobindo Pharma#39;s wholly owned subsidiary company, Eugia Pharma Specialities Limited received a final approval from the US Food Drug Administration (USFDA) to manufacture and market Azacitidine for Injection, 100 mg single-dose vial. Aurobindo Pharma#39;s wholly owned subsidiary company, Eugia Pharma Specialities Limited received a final approval from the US Food Drug Administration (USFDA) to manufacture and market Azacitidine for Injection, 100 mg single-dose vial.  Moneycontrol Latest News Read More  

Aurobindo Pharma#39;s wholly owned subsidiary company, Eugia Pharma Specialities Limited received a final approval from the US Food Drug Administration (USFDA) to manufacture and market Azacitidine for Injection, 100 mg single-dose vial.

Aurobindo Pharma trades in red despite FDA nod to Eugia Pharma injection

Aurobindo Pharma trades in red despite FDA nod to Eugia Pharma injection

Aurobindo Pharma#39;s wholly owned subsidiary company, Eugia Pharma Specialities Limited received a final approval from the US Food Drug Administration (USFDA) to manufacture and market Azacitidine for Injection, 100 mg single-dose vial.

Read More

​ Aurobindo Pharma#39;s wholly owned subsidiary company, Eugia Pharma Specialities Limited received a final approval from the US Food Drug Administration (USFDA) to manufacture and market Azacitidine for Injection, 100 mg single-dose vial. Aurobindo Pharma#39;s wholly owned subsidiary company, Eugia Pharma Specialities Limited received a final approval from the US Food Drug Administration (USFDA) to manufacture and market Azacitidine for Injection, 100 mg single-dose vial.  Moneycontrol Latest News Read More  

Aurobindo Pharma#39;s wholly owned subsidiary company, Eugia Pharma Specialities Limited received a final approval from the US Food Drug Administration (USFDA) to manufacture and market Azacitidine for Injection, 100 mg single-dose vial.

What InCred Money’s acquisition of Orowealth tells us about the wealth-tech industry

What InCred Money’s acquisition of Orowealth tells us about the wealth-tech industry

Tighter SEBI guidelines around mutual fund distribution and advisory services, investors’ reluctance to pay a fee, and low awareness have forced robo-advisors to keep reinventing the wheel.

Read More

​ Tighter SEBI guidelines around mutual fund distribution and advisory services, investors’ reluctance to pay a fee, and low awareness have forced robo-advisors to keep reinventing the wheel. Tighter SEBI guidelines around mutual fund distribution and advisory services, investors’ reluctance to pay a fee, and low awareness have forced robo-advisors to keep reinventing the wheel.  Moneycontrol Latest News Read More  

Tighter SEBI guidelines around mutual fund distribution and advisory services, investors’ reluctance to pay a fee, and low awareness have forced robo-advisors to keep reinventing the wheel.

Rishabh Pant set to be shifted to Mumbai for treatment of his ligament injury

Rishabh Pant set to be shifted to Mumbai for treatment of his ligament injury

Rishabh Pant, 25, survived a horrific car accident when he was driving down from Delhi to his hometown Rourkee but lost control on NH-58 highway and hit the divider.

Read More

​ Rishabh Pant, 25, survived a horrific car accident when he was driving down from Delhi to his hometown Rourkee but lost control on NH-58 highway and hit the divider. Rishabh Pant, 25, survived a horrific car accident when he was driving down from Delhi to his hometown Rourkee but lost control on NH-58 highway and hit the divider.  Moneycontrol Latest News Read More  

Rishabh Pant, 25, survived a horrific car accident when he was driving down from Delhi to his hometown Rourkee but lost control on NH-58 highway and hit the divider.

SC to hear plea against removal of encroachments in Haldwani on January 5

SC to hear plea against removal of encroachments in Haldwani on January 5

A bench comprising Chief Justice D Y Chandrachud and Justices S A Nazeer and P S Narasimha posted the matter for hearing after advocate Prashant Bhushan mentioned the matter.

Read More

​ A bench comprising Chief Justice D Y Chandrachud and Justices S A Nazeer and P S Narasimha posted the matter for hearing after advocate Prashant Bhushan mentioned the matter. A bench comprising Chief Justice D Y Chandrachud and Justices S A Nazeer and P S Narasimha posted the matter for hearing after advocate Prashant Bhushan mentioned the matter.  Moneycontrol Latest News Read More  

A bench comprising Chief Justice D Y Chandrachud and Justices S A Nazeer and P S Narasimha posted the matter for hearing after advocate Prashant Bhushan mentioned the matter.

Satya Nadella advocates use of tech for driving inclusivity, empowerment; says Microsoft very committed to India

Satya Nadella advocates use of tech for driving inclusivity, empowerment; says Microsoft very committed to India

Satya Nadella was speaking at Microsoft#39;s Tech for Good and Education showcase, an event that highlighted the impact created by technology in the areas of philanthropic work and education.

Read More

​ Satya Nadella was speaking at Microsoft#39;s Tech for Good and Education showcase, an event that highlighted the impact created by technology in the areas of philanthropic work and education. Satya Nadella was speaking at Microsoft#39;s Tech for Good and Education showcase, an event that highlighted the impact created by technology in the areas of philanthropic work and education.  Moneycontrol Latest News Read More  

Satya Nadella was speaking at Microsoft#39;s Tech for Good and Education showcase, an event that highlighted the impact created by technology in the areas of philanthropic work and education.

Sah Polymers IPO bought 8.29 times on final day, retail portion booked 24.17 times

Sah Polymers IPO bought 8.29 times on final day, retail portion booked 24.17 times

Sah Polymers IPO | The customised bulk packaging solutions provider launched its Rs 66.3-crore public issue for subscription on December 30, with a price band of Rs 61-65 per share.

Read More

​ Sah Polymers IPO | The customised bulk packaging solutions provider launched its Rs 66.3-crore public issue for subscription on December 30, with a price band of Rs 61-65 per share. Sah Polymers IPO | The customised bulk packaging solutions provider launched its Rs 66.3-crore public issue for subscription on December 30, with a price band of Rs 61-65 per share.  Moneycontrol Latest News Read More  

Sah Polymers IPO | The customised bulk packaging solutions provider launched its Rs 66.3-crore public issue for subscription on December 30, with a price band of Rs 61-65 per share.

Gold Prices Today: Volatility to rule amid macro concerns, strong dollar, FOMC minutes

Gold Prices Today: Volatility to rule amid macro concerns, strong dollar, FOMC minutes

The dollar index jumped 1 percent that put pressure on precious metals. The market focus is now on the release on Wednesday of the minutes from the Fed#39;s December 13-14 policy meeting as well as other economic data expected this week, said Rahul Kalantri, VP Commodities at Mehta Equities.

Read More

​ The dollar index jumped 1 percent that put pressure on precious metals. The market focus is now on the release on Wednesday of the minutes from the Fed#39;s December 13-14 policy meeting as well as other economic data expected this week, said Rahul Kalantri, VP Commodities at Mehta Equities. The dollar index jumped 1 percent that put pressure on precious metals. The market focus is now on the release on Wednesday of the minutes from the Fed#39;s December 13-14 policy meeting as well as other economic data expected this week, said Rahul Kalantri, VP Commodities at Mehta Equities.  Moneycontrol Latest News Read More  

The dollar index jumped 1 percent that put pressure on precious metals. The market focus is now on the release on Wednesday of the minutes from the Fed#39;s December 13-14 policy meeting as well as other economic data expected this week, said Rahul Kalantri, VP Commodities at Mehta Equities.

More US consumers want EVs but prices are a concern: Deloitte survey

More US consumers want EVs but prices are a concern: Deloitte survey

Nearly 7 in 10 prospective EV buyers in the United States expect to pay less than $50,000 for their next vehicle, according to the survey conducted between September and October 2022.

Read More

​ Nearly 7 in 10 prospective EV buyers in the United States expect to pay less than $50,000 for their next vehicle, according to the survey conducted between September and October 2022. Nearly 7 in 10 prospective EV buyers in the United States expect to pay less than $50,000 for their next vehicle, according to the survey conducted between September and October 2022.  Moneycontrol Latest News Read More  

Nearly 7 in 10 prospective EV buyers in the United States expect to pay less than $50,000 for their next vehicle, according to the survey conducted between September and October 2022.

en_USEnglish